SCHEMBL1940481

SCHEMBL1940481

Cc1ccc(NC(=O)Nc2cc(F)ccc2F)cc1C(=O)c1cn(C(C)C)c2ncnc(N)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 4/20 0.60
NTRK2 Q16620 4/20 0.60
NTRK3 Q16288 2/20 0.60
PDGFRB P09619 1/20 0.58
KCNH2 Q12809 3/20 0.51
TEK Q02763 2/20 0.49
EGFR P00533 1/20 0.49
ERBB2 P04626 1/20 0.49
ERBB3 P21860 1/20 0.49
ERBB4 Q15303 1/20 0.49
RET P07949 6/20 0.48
LCK P06239 3/20 0.47
SRC P12931 2/20 0.47
PDPK1 O15530 6/20 0.43
FLT3 P36888 2/20 0.43
KDR P35968 2/20 0.42
AURKA O14965 1/20 0.42
ROCK2 O75116 1/20 0.42
RPS6KA5 O75582 1/20 0.42
MAP4K4 O95819 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1939895 0.95 NTRK1 (0.62) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1942082 0.93 NTRK1 (0.69) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1941182 0.93 PDGFRB (0.58) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1941593 0.92 PDGFRB (0.60) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1941229 0.92 PDGFRB (0.63) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1940197 0.91 PDGFRB (0.62) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1940270 0.90 PDGFRB (0.61) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1941220 0.89 PDGFRB (0.65) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1940387 0.89 PDGFRB (0.60) NTRK1NTRK2NTRK3PDGFRBKCNH2
SCHEMBL1942671 0.88 PDGFRB (0.64) NTRK1NTRK2NTRK3PDGFRBKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP disclosed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 NTRK1 4135/4885NTRK2 4651/4885NTRK3 4212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.